$13.80 +2.25 (19.48%) Sarepta Therapeutics Inc - NASDAQ

Apr. 28, 2016 | 04:00 PM

Charts

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Key Statistics
Last Trade: 13.80
Trade Time: Apr 28 04:00 PM Eastern Daylight Time
Change: +2.25 (19.48%)
Prev Close: 11.55
Open: 13.73
Bid: 13.80
Ask: 13.81

Competitors

Ticker Name Volume % Change
ABBV AbbVie Inc 16.13M +0.82%
BA Boeing Co 4.89M -1.66%
AMGN Amgen Inc 3.34M -0.27%
ALXN Alexion Pharmaceuticals Inc 3.27M -5.47%
EXEL Exelixis Inc 2.98M -0.44%

SRPT Stock Analysis

  1. No results found.

Partner Headlines

  1. Sarepta Says FDA Postpones Advisory Committee Meeting to Review Eteplirsen Due to ...

    Benzinga | Jan. 20, 2016 | 19:44PM EST
  2. Benzinga's Top Downgrades

    Benzinga | Jan. 19, 2016 | 09:30AM EST
  3. Sarepta drops on FDA release

    IBD | Jan. 15, 2016 | 18:43PM EST
  4. Sarepta Plummets As FDA Slams Muscular Dystrophy Drug

    IBD | Jan. 15, 2016 | 12:53PM EST
  5. BioMarin Muscular Dystrophy Drug Rejected By FDA

    IBD | Jan. 14, 2016 | 12:29PM EST
  6. FDA Panel Seen As Bad For BioMarin, Good For Sarepta

    IBD | Nov. 25, 2015 | 14:34PM EST